Medplus Health Services Ltd

NSE: MEDPLUS · BSE: 543427 · Healthcare · 120 announcements

Share price: ₹625.80
Market cap: ₹7,519 Cr
Revenue (annual): ₹6,892 Cr
Net profit (annual): ₹219.7 Cr
P/E (TTM): 35.6×Sector 54.5×
Promoter holding: 40.19%+0.00% QoQ
FII holding: 12.58%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Adverse Business Impact 2 Capital Structure Change 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

12 Nov 2026 18:12 IST NSE

Adverse Business Impact

Medplus Health Services Adverse Business Impact

Medplus subsidiary Optival Health received a two-day drug licence suspension for its Kothagudem store. Expected financial impact is Rs 0.44 lacs, and compliance measures are underway.

Value: ₹0.00 Cr

Open announcement → Read the filing ↗

8 Nov 2026 15:41 IST BSE

Adverse Business Impact

Medplus Health Services Adverse Business Impact

MedPlus stores in Karnataka face four-day drug licence suspensions. Expected financial impact is about Rs 4.06 lacs.

Value: ₹0.04 Cr
Execution: Four days

Open announcement → Read the filing ↗